PEN FY 2021 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

FY 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$748M+33.4% YoY

Gross Profit

$475M63.6% margin

Operating Income

-$8M-1.0% margin

Net Income

$5M0.7% margin

EPS (Diluted)

$0.14

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

-$12M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$290M

Stockholders' Equity

$954M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$748M	$560M	+33.4%
Gross Profit	$475M	$338M	+40.6%
Operating Income	-$8M	-$39M	+80.7%
Net Income	$5M	-$16M	+133.7%